Search
-
News
Our recent research confirms that total gastrectomy should be considered for all patients with the CDH1 gene mutation that carries a high risk for developing hereditary diffuse gastric cancer.
… Friday, January 5, 2018 Our recent research confirms that total gastrectomy should be considered for all patients with the CDH1 gene mutation that carries a high risk for developing hereditary diffuse gastric cancer. In our study, published in the Annals of Surgery in December 2017, none of the 41 patients
-
News
For people who are unable to find a matched bone marrow or stem cell donor, a cord blood transplant may offer the best chance for being cured of blood cancer.
… Thursday, August 30, 2018 Summary For people who don’t have a matched bone marrow or stem cell donor, a cord blood transplant may offer the best chance for being cured of blood cancer. Allogeneic stem cell or bone marrow transplants can be lifesavers for people with a blood cancer such as leukemia or
-
News
An effort to develop a radiation test after 9/11 inspires a trip through medical history.
… Wednesday, September 7, 2016 Summary Efforts to understand the effect of radiation on healthy tissues and cancer in the body have a long history. An MSK doctor was inspired to explore that history after helping to develop a test to detect radiation exposure. Highlights Simple blood tests to assess radiation
-
News
Learn what bladder cancer symptoms can mean in men and women.
… Wednesday, October 26, 2022 Bladder cancer does not affect men and women in the same ways. Knowing the warning signs of bladder cancer can lead to early diagnosis, which greatly improves outcomes. Bladder cancer is the sixth most common cancer in the United States. But there are differences between men
-
News
Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.
… Wednesday, March 13, 2013 Summary Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells. Scientists from Memorial Sloan Kettering have discovered
-
News
Learn about research on lymphedema at Memorial Sloan Kettering Cancer Center, which finds that Black and Hispanic women are at highest risk.
… Wednesday, April 3, 2024 Update: Dr Andrea Barrio and colleagues from MSK published a study in JAMA Network in March 2024, which found that Black, Hispanic, and Asian women with breast cancer experience more arm symptoms and worse quality of life than white women after axillary lymph node dissection,
-
News
MSK Kids, the pediatric oncology program at Memorial Sloan Kettering Cancer Center (MSK) has been named one of the best children’s hospitals nationally, according to U.S. News & World Report in its annual “Best Children’s Hospitals” list. MSK Kids is ranked 13th in the nation. MSK Kids has been ranked by U.S. News & World Report for the past 12 years.
… Tuesday, June 16, 2020 MSK Kids , the pediatric oncology program at Memorial Sloan Kettering Cancer Center (MSK) has been named one of the best children’s hospitals nationally, according to U.S. News & World Report in its annual “Best Children’s Hospitals” list. MSK Kids is ranked 13th in the nation.
-
News
A new resource provides a comprehensive list of human proteins that could trigger autoimmune symptoms in ‘long COVID’ patients.
… Monday, May 24, 2021 Approximately 10% of people who contract COVID-19 will develop lingering symptoms — fever, fatigue, blood clots, or brain fog — that can last for months. The underlying cause of “long COVID” is not yet known, but one hypothesis is autoimmune reactions. An autoimmune reaction occurs
-
News
Discover how MSK Kids is using medical play to help children understand treatments and procedures.
… Thursday, December 5, 2019 Summary Medical play is an important component of care at MSK Kids. Learn how child life specialists teach young children and prepare them for their treatments. A hospital can be an unnerving place for anyone, regardless of age. But for children, the environment may be totally
-
News
Learn about George Bosl, who will become MSK's first ombudsperson.
… Friday, July 5, 2019 Summary George Bosl, who spent nearly two decades as Chair of MSK’s Department of Medicine , will become the institution’s first ombudsperson. The position will be a resource for employees to guide them through conflicts of interest and related issues. As Chair of Memorial Sloan